TopNewsOn

Results for “prostate cancer”

The surprising cancer connection at the heart of Alzheimer's

People say "the body keeps score"—but it might be more accurate to say our neurons do. In healthy people, neurons accumulate about 17 single-nucleotide variants each year, a pattern that holds from birth through a person's final years, according to research from HHMI investigator Chris Walsh and others.

Medical Xpress · 23h ago
Newly discovered mechanism may help ovarian cancer cells silence tumor-suppressor genes

Researchers at Umeå University have discovered how chemical marks on RNA control a DNA methylation enzyme and contribute to the silencing of tumor-suppressor genes in ovarian cancer cells. The findings provide new insights into the disease and may, in the long term, contribute to the development of new treatment strategies for high-grade serous ovarian carcinoma.

Medical Xpress · Nov 19
Commonly mutated gene could be a therapeutic target in sarcoma

Researchers at The University of Texas MD Anderson Cancer Center have discovered that sarcomas lacking the ATRX gene tend to be more aggressive and may be particularly vulnerable to a class of targeted therapies known as TEAD inhibitors. The findings identify ATRX loss as both a marker of poor prognosis and a potential therapeutic target.

Medical Xpress · Nov 19
Novel CAR-T platform uses radiation-activated switch to destroy tumors more effectively

Engineering patients' own immune cells to find and destroy cancer using chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of blood cancers. However, its use is limited in solid tumors because the immunosuppressive tumor microenvironment prevents CAR T-cell entry into the tumor and causes cells that enter to become exhausted.

Medical Xpress · Nov 19
Children exposed to more radiation from medical scans may face higher brain tumor risk

A new large study led by UC Davis and UC San Francisco researchers has found that higher cumulative radiation dose to the brain from medical imaging during childhood is linked to a greater brain tumor risk in children and adolescents. Brain tumors are the second most common childhood cancers and are the leading cause of cancer death among children and adolescents.

Medical Xpress · Nov 19
Predictive biomarker for liver cancer associated with survival outcomes, effectiveness of systemic therapy

Liver cancer was the sixth most common cancer and the third leading cause of cancer-related deaths worldwide in 2022, with hepatocellular carcinoma (HCC) as the most common histological subtype, accounting for approximately 90% of liver cancers. Despite this, biomarkers that predict survival and therapeutic response to atezolizumab plus bevacizumab (Atezo/Bev), a type of systemic therapy in HCC management, have yet to be established in unresectable HCC, in which the tumor cannot be safely treated via surgical removal.

Medical Xpress · Nov 19
Researchers find two understudied 'forever chemicals' raise liver cancer risk

A first-of-its-kind USC study links two little-studied "forever chemicals" to liver cancer, with the greatest risk in those already genetically susceptible to fatty liver disease. The study, published in Environmental Health Perspectives, finds that two per- and polyfluoroalkyl substances (PFAS), also known as "forever chemicals," are associated with a significantly higher risk of liver cancer, with the strongest effects in people genetically predisposed to metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease.

Medical Xpress · Nov 19
MRI advance could help monitor fatty liver disease by revealing enzyme activity

Researchers in Japan have, for the first time, visualized the activity of an important liver enzyme in vivo using an MRI-based approach, potentially providing a new way to detect and monitor fatty liver disease. The condition can progress with few obvious warning signs and, in severe cases, can lead to liver inflammation, fibrosis, cirrhosis and liver cancer.

Medical Xpress · Nov 18
Researchers compare AI tools for analyzing tumor tissue

Researchers at Skoltech, the University of Sharjah in the United Arab Emirates and Tokai University in Japan, together with colleagues, have published an open-access review of computer vision in histopathology. The review examines how algorithms can identify tissue features in lung, breast, colorectal and prostate cancers.

Medical Xpress · Nov 18
An mRNA booster for cellular immunotherapy shows potential against aggressive brain tumors

A team led by researchers at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) has developed a new approach to more effectively direct immune cells against glioblastomas. In experimental models, they were able to show that a targeted mRNA vaccine significantly increases the potency of therapeutic immune cells. The paper is published in the journal Cancer Research.

Medical Xpress · Nov 18
Dual-targeted CAR T-cell therapy shows promise in patients with treatment-resistant multiple myeloma

A first-in-human study by Mass General Brigham Cancer Institute investigators found that a chimeric antigen receptor (CAR) T-cell therapy called TriPRIL reduced or eliminated signs of cancer in 12 of 15 patients with relapsed or refractory multiple myeloma. TriPRIL—short for trimeric APRIL (a proliferation-inducing ligand)—recognizes two proteins on myeloma cells instead of just one. Researchers published their findings in The Lancet.

Medical Xpress · Nov 18
How cancer cells protect themselves from a toxin they produce

Cancer cells must protect themselves from the harmful substances they produce as they grow. Now, researchers have identified how they neutralize one of these substances, formaldehyde, while keeping another defense against cell death intact. The findings suggest a way to attack both defenses together, and the next step is to find out whether it could become a treatment.

Medical Xpress · Nov 18
Study finds some BRCA2 gene changes carry lower breast cancer risk

Mayo Clinic researchers, in a study published in Nature Communications, have identified a group of BRCA2 gene variants associated with a moderate risk of breast cancer, a finding that could help health care teams better assess a person's cancer risk and personalize care.

Medical Xpress · Nov 18
Experimental blood test can detect four signs of deadly diseases in an hour

A new diagnostic platform is able to screen for and identify four different diseases—colorectal cancer, glioblastoma, pancreatic cancer and Alzheimer's disease—with a small amount of blood in an hour. The patent-pending technology was developed by a team of researchers led by Hsueh-Chia Chang at the University of Notre Dame.

Medical Xpress · Nov 17
A new tool to predict T cell behavior and improve immunotherapies

T cells are the trained killers of the immune system and the driving force behind cancer immunotherapy. But the behavior of T cells is hard to predict: Some spring into action when prompted, while others become lethargic and aimless. This puzzling inconsistency is one of the main reasons immunotherapies don't work in most cancer patients.

Medical Xpress · Nov 17
Understanding how inflammation begins so scientists can end it

Chronic inflammation is a major factor in arthritis, type 2 diabetes, Alzheimer's disease and cancer. A new tool developed at UC Riverside allows researchers to see exactly how inflammation begins in human cells. In their study published in Free Radical Biology and Medicine, researchers used cells lining the airways, as these come into direct contact with inhaled, inflammation-triggering pollutants. Learning what sets off this inflammation on a cellular level could eventually help researchers find ways to stop it from becoming chronic.

Medical Xpress · Nov 17
Study tracks RAMP3's role in breast cancer immunity in mice

Cancer immunotherapy uses the body's defenses to attack cancer, but it does not help every patient. One reason may be the environment surrounding a tumor. Macrophages normally clear damaged cells, but some can suppress immune responses inside tumors, making it harder for cancer-fighting cells to work.

Medical Xpress · Nov 17
From supply chains to cancer research: How causal AI is opening new research paths

How can automotive supply-chain research inform a new line of inquiry in cancer treatment research? For Constructor University Lecturer and Postdoctoral Researcher Ishansh Gupta, the answer is causal AI—a form of artificial intelligence that goes beyond simple pattern recognition to analyze why certain patterns exist, and help predict outcomes of changes.

Medical Xpress · Nov 16
The spatial arrangement of DNA can shape the characteristics of blood cancer

Acute myeloid leukemia (AML) is a malignant disorder of the hematopoietic system in the bone marrow, affecting an early precursor stage of what are known as myeloid cells. In healthy people, these cells develop into red blood cells, platelets and some white blood cells—a process that is normally strictly regulated.

Medical Xpress · Nov 16
Making tumor cells easier for T cells to recognize

Immunotherapy has transformed cancer treatment, but not all patients experience long-term benefit, as tumor cells can develop ways of evading the immune system. In his doctoral thesis, Lucas Baldran at the Department of Oncology-Pathology investigated whether changes within tumor cells could improve their recognition by T cells, immune cells that can recognize and attack cancer cells. The thesis was supervised by PhD Jeroen Melief. The public defense took place on October 23.

Medical Xpress · Nov 16
Lymph node removal during palliative gastrectomy for stage IV gastric cancer shows no short-term harm

A research team examined the association between lymph node dissection and short-term outcomes after palliative, noncurative gastrectomy for stage IV gastric cancer. The team was led by professor Jae-Seok Min of the Division of Foregut Surgery, Department of Surgery, at Korea University Anam Hospital and professor Sang-Ho Jeong of the Department of Surgery at Gyeongsang National University Changwon Hospital. The work is published in the World Journal of Surgery.

Medical Xpress · Nov 16
Dual-action bacterial cancer therapy shrinks aggressive breast tumors in mouse models

Tumors that resist immune attack, recur and spread pose a major challenge to cancer treatment. Because certain bacteria naturally accumulate within tumors, they serve as potential carriers for anticancer agents. Addressing this, a research team from the Republic of Korea—led by professor John Hwa Lee from the Laboratory of Veterinary Public Health, College of Veterinary Medicine, Jeonbuk National University—developed an engineered strain of Salmonella Typhimurium carrying two anticancer components.

Medical Xpress · Nov 16
Finally, a Vaccine for Cancer

An experimental vaccine has been found to prevent recurrence of melanoma. Scientists hope it won’t be the last.

The New York Times · Nov 16